New drug trial targets hardening skin in rare autoimmune disease
NCT ID NCT05198557
Summary
This study is testing whether an investigational drug called MT-0551 can reduce skin thickening in people with systemic sclerosis, a rare autoimmune disease that causes hardening of the skin and internal organs. The trial will compare MT-0551 against a placebo in 80 patients over 26 weeks, measuring changes in skin thickness and lung function. The goal is to see if the drug can better control disease progression and improve patients' symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Kanazawa University Hospital
Kanazawa, Ishikawa-ken, 920-8641, Japan
-
St. Marianna University Hospital
Kawasaki-shi, Kanagawa, 216-8511, Japan
-
The University of Tokyo Hospital
Bunkyo-ku, Tokyo, 113-8655, Japan
-
University of Fukui Hospital
Yoshida-gun, Fukui, 910-1193, Japan
Conditions
Explore the condition pages connected to this study.